In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Organogenesis Holdings Inc’s stock clocked out at $3.12, up 0.65% from its previous closing price of $3.10. In other words, the price has increased by $0.65 from its previous closing price. On the day, 0.62 million shares were traded. ORGO stock price reached its highest trading level at $3.175 during the session, while it also had its lowest trading level at $3.09.
Ratios:
To gain a deeper understanding of ORGO’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 103.17. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 3.09. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On February 07, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $5.
On June 15, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $5.Morgan Stanley initiated its Equal-Weight rating on June 15, 2023, with a $5 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when Gillheeney Gary S. sold 55,615 shares for $3.36 per share. The transaction valued at 186,866 led to the insider holds 3,044,779 shares of the business.
Gillheeney Gary S. sold 5,585 shares of ORGO for $19,492 on Dec 16 ’24. The President and CEO now owns 3,039,194 shares after completing the transaction at $3.49 per share. On Dec 11 ’24, another insider, Gillheeney Gary S., who serves as the President and CEO of the company, sold 157,448 shares for $3.64 each. As a result, the insider received 573,111 and left with 3,143,753 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGO now has a Market Capitalization of 392265120 and an Enterprise Value of 426966688. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.88 while its Price-to-Book (P/B) ratio in mrq is 1.48. Its current Enterprise Value per Revenue stands at 0.938 whereas that against EBITDA is 14.858.
Stock Price History:
The Beta on a monthly basis for ORGO is 1.76, which has changed by -0.28406465 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, ORGO has reached a high of $4.70, while it has fallen to a 52-week low of $2.16. The 50-Day Moving Average of the stock is -9.58%, while the 200-Day Moving Average is calculated to be 6.01%.
Shares Statistics:
It appears that ORGO traded 708.57K shares on average per day over the past three months and 558850 shares per day over the past ten days. A total of 132.58M shares are outstanding, with a floating share count of 67.50M. Insiders hold about 46.31% of the company’s shares, while institutions hold 51.05% stake in the company. Shares short for ORGO as of 1734048000 were 10998854 with a Short Ratio of 15.52, compared to 1731628800 on 10408686. Therefore, it implies a Short% of Shares Outstanding of 10998854 and a Short% of Float of 38.15.
